Clinical stage biopharmaceutical company Paradigm Biopharmaceuticals (ASX: PAR) has been given the green light to go ahead with a Phase 2 study of their flagship drug, pentosan polysulfate sodium (PPS) in patients with Mucopolysaccharidosis type VI (MPS VI). A big word to digest on a Friday morning, I know. The inherited disease is caused by
Read More
Invented in 1895 and becoming the standard in the early 1900s, the x-ray has long been the backbone of many medical diagnoses. The relatively unchanged technology has been commonplace for decades, but medtech company 4D Medical (ASX: 4DX) is rethinking the way we diagnose respiratory issues with their proprietary XV Technology™ and Permetium preclinical scanner.
Read More
With the price of Bitcoin appearing to have found its newest support level amid the price boom which sent BTC to it’s all-time high, data centre company DC Two (ASX: DC2) has found an innovative way to capitalise, leasing out modular data centres to miners seeking to reduce their power consumption expenses. The process of
Read More
If you haven’t seen the ads that have been peppering Australian television and media over the past week, Amazon Prime Day is coming on June 21 and 22 which means there’s going to be a flurry of retail activity that ASX investors can keep an eye on. Although Amazon’s entry in the Australian market is
Read More
With such an increase in time spent at home over the past year as a result of the pandemic, it seems not all Australians are enjoying each other’s company as evidenced by the rise in filings from family law specialists AF Legal (ASX: AFL). So busy has the firm been, it’s now added large offices
Read More
The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter with the Company reporting strong revenue. The Company was founded to develop and commercialise the RECELL “spray-on skin” product, invented in Perth by Professor Fiona Wood. Professor Wood is a world renowned surgeon and researcher
Read More
While the future on when Aussies can holiday overseas remains unclear, one company is seizing the opportunity that has now become the norm since the pandemic, domestic tourism. Camplify (Proposed ASX code: CHL), is an online platform which connects owners of campervans, caravans, and motorhomes to keen outdoor holidaymakers, renting them out in a similar
Read More
At a time when Buy Now Pay Later companies have disrupted the Australian credit economy, Cash Converters (ASX: CCV) is making a strong comeback in the personal finance sector having transitioned away from their image as opportunistic pawnbrokers. The renaissance of Cash Converters which has increased marketing spend, evidenced through television advertising that features prominent
Read More
The keto diet is proving to be more than just another “It” diet touted by Goop with interesting research showing that it may have a place in cancer treatment. Eating a keto diet puts the body in a state of ketogenesis where instead of running off glucose based energy, the body is fueled by fats
Read More
A new treatment for the deadly bone marrow cancer myelofibrosis is one step closer to a FDA application with clinical stage drug development company Pharmaxis (ASX: PXS) having successfully completed dosing of the first stage of its current trial. With the first dosing of PXS-5505 confirmed as safe by the study’s safety monitoring committee, Pharmaxis
Read More
